EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lycium barbarum Glycopeptide Alleviates Neomycin‐Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase‐Mediated Serotonin Biosynthesis

Yunhao Wu iD, Li Zhang, Shengda Cao, Jingwen Zhang, Cheng Li, Yunlong Shan, Qiuping Liu, Zhexiong Yu, Qiaojun Fang, Yuhua Zhang, Xiaolong Fu, Kwok-Fai So und 1 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202405850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yunhao Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, China. Hauptthemen laut MEDLINE: Neomycin, Serotonin, Tryptophan Hydroxylase, Ototoxicity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Strategic Priority Research Program of the Chinese Academy of Science, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aminoglycoside antibiotic‐induced sensorineural hearing loss (SNHL) is a common sensory disorder that requires the development of prophylactic and therapeutic interventions. Lycium barbarum glycopeptide (LBGP) is a peptidoglycan isolated and purified from Lycium barbarum polysaccharides that exhibit significant anti‐inflammatory, antioxidant, and neuroprotective effects, but the role of LBGP in aminoglycoside‐induced SNHL has not been well investigated. Here it is shown that LBGP can protect against neomycin‐induced hearing impairment and alleviate oxidative stress in a neomycin‐induced SNHL mouse model. Moreover, it is further found that inhibition of tryptophan hydroxylase (Tph)‐mediated serotonin (5‐HT) biosynthesis plays a key role in the mechanism of action of LBGP in treating neomycin‐induced hearing loss. Systemic delivery of 5‐HT increased neomycin‐induced apoptosis of cochlear hair cells and spiral ganglion neurons, and pharmacological Tph2 inhibition with P‐chlorophenylalanine or Tph2 knock down by AAV‐ie‐ Tph2 effectively attenuated neomycin‐induced hearing dysfunction. Collectively, these results provide a promising strategy for the prevention of SNHL by using natural plant extract which is more available and exhibits lower side effects compared with other otoprotective drugs, and identify Tph2 as a potential pharmacological target for the treatment of aminoglycoside‐induced ototoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeomycinSerotoninTryptophan HydroxylaseOtotoxicityGlycopeptidesHearing Loss, SensorineuralDrugs, Chinese HerbalAnimalsMiceDisease Models, AnimalMaleOxidative StressLyciumMice, Inbred C57BLHair Cells, Auditory

Stichwörter der Autor:innen

Lycium barbarum glycopeptideP‐chlorophenylalaninesensorineural hearing losstryptophan hydroxylasetryptophan metabolism

Substanzen

NeomycinSerotoninTryptophan HydroxylaseGlycopeptidesDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, China.
  • State Key Laboratory of Digital Medical Engineering, Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, School of Life Sciences and Technology, Advanced Institute for Life and Health, Jiangsu Province…
  • Key Laboratory of CNS Regeneration (Ministry of Education), Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, 510632, China.
  • Department of Otorhinolaryngology, Qilu Hospital of Shandong University, NHC Key Laboratory of Otorhinolaryngology (Shandong University), Jinan, 250063, China.
  • Department of Otolaryngology-Head and Neck, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
  • Yixing Traditional Chinese Medicine Hospital, Yixing, 214299, China.

ORCID-Profile: Yunhao Wu, Renjie Chai

Förderung

  • National Key Research and Development Program of China
  • Strategic Priority Research Program of the Chinese Academy of Science
  • National Natural Science Foundation of China
  • STI2030-Major Projects
  • Science and Technology Department of Sichuan Province
  • Shenzhen Science and Technology Program
  • Young Scientists Fund of Shandong First Medical University (Shandong Academy of Medical Sciences)
  • Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University

Zitieren

APA

Wu, Y., Zhang, L., Cao, S., Zhang, J., Li, C., Shan, Y., Liu, Q., Yu, Z., Fang, Q., Zhang, Y., Fu, X., So, K. F., & Chai, R. (2025). Lycium barbarum Glycopeptide Alleviates Neomycin‐Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase‐Mediated Serotonin Biosynthesis. Advanced Science. https://doi.org/10.1002/advs.202405850

Vancouver

Wu Y, Zhang L, Cao S, Zhang J, Li C, Shan Y, et al. Lycium barbarum Glycopeptide Alleviates Neomycin‐Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase‐Mediated Serotonin Biosynthesis. Advanced Science. 2025. doi:10.1002/advs.202405850

BibTeX
@article{Wu2025,
  author = {Wu, Yunhao and Zhang, Li and Cao, Shengda and Zhang, Jingwen and Li, Cheng and Shan, Yunlong and Liu, Qiuping and Yu, Zhexiong and Fang, Qiaojun and Zhang, Yuhua and Fu, Xiaolong and So, Kwok-Fai and Chai, Renjie},
  title = {Lycium barbarum Glycopeptide Alleviates Neomycin‐Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase‐Mediated Serotonin Biosynthesis},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202405850}
}
Kostenlos starten →